Technology & innovation

This archive covers technology and innovation breakthroughs that improve lives, protect the environment, and expand human possibility. From medical devices to clean energy tools, the stories here focus on what’s working and who’s making it happen.

Ghanaian child carrying load on head, for article on R21 malaria vaccine

Ghana first country to approve ‘world-changer’ malaria vaccine

By / / Good News For Humankind

Ghana’s approval of the R21 malaria vaccine — the first anywhere in the world — clears the way for children as young as five months to be protected against a disease that kills roughly 620,000 people every year, mostly young kids in Africa. Developed at Oxford’s Jenner Institute, R21 showed up to 80% effectiveness in early trials and is expected to cost just a couple of dollars per dose. The Serum Institute of India is preparing to produce up to 200 million doses a year, with a factory rising in Accra so supply stays close to home. After a century of scientific near-misses, an African regulator stepped forward and said: this one is ready.

Patient with IV, for article on primary bone cancer drug

Breakthrough drug works against all the main types of primary bone cancer

By / / Good News For Humankind

Bone cancer research has taken a meaningful step forward, with scientists identifying a single drug candidate that shows activity across all the major types of primary bone cancer — a group of diseases that have long resisted a unified treatment approach. Because these cancers disproportionately affect children and young people, the stakes are especially high. The compound appears to target something the different subtypes share biologically, which could open new research directions well beyond this one discovery. For pediatric cancer medicine, that kind of insight builds the foundation treatments are eventually made from.\n\nWord count: 88

Scientist examines the result of a plaque assay, for article on gene therapy cure MLD

Researchers cure toddler of deadly metachromatic leukodystrophy (MLD) for first time in history

By / / Good News For Humankind

Gene therapy has cured 19-month-old Teddi Shaw of metachromatic leukodystrophy, making her the first NHS patient treated for this rare, fatal nervous system disease. After a single infusion of Libmeldy at Royal Manchester Children’s Hospital, she’s now running around, chattering away, and showing no signs of the illness that typically kills children before age eight. The treatment works by correcting a faulty gene in the child’s own stem cells, eliminating the disease at its root rather than managing it. Her family’s joy is tempered by grief — Teddi’s older sister was diagnosed too late for the therapy to help, fueling calls for newborn screening. It’s a glimpse of medicine’s next era: one-time cures for inherited conditions, if access and early detection can keep pace.

Depiction of spiral-welded wind turbine construction, for article on spiral-welded wind turbine tower

GE installs world’s first spiral-welded wind turbine tower

By / / Good News For Humankind

Spiral-welded wind turbine towers could quietly dissolve one of the biggest barriers holding back wind energy: the highway. Because conventional towers must be trucked in, U.S. road regulations cap their diameter — and therefore their height — well below what the physics of wind actually allows. Keystone’s mobile factories build towers on-site from coiled steel, removing that constraint entirely and making towers tall enough to reach stronger, more consistent winds. One tower doesn’t rewrite the industry, but it proves the concept works. If the approach scales, it could bring competitive wind energy to regions that have never had it.

Fungal infection under microscope, for article on pan-fungal vaccine

First vaccine to target deadly fungal infections passes preclinical tests

By / / Good News For Humankind

Fungal infections kill an estimated 1.6 million people every year, yet until now no vaccine has ever existed for any of the major culprits. Researchers at the University of Georgia have developed a single shot that trains the immune system to recognize all three deadliest fungal genera simultaneously — a feat never before demonstrated in peer-reviewed research. Crucially, it reduced illness and death in immunocompromised animals, the very people most at risk. For a disease category the WHO only recently recognized as a global emergency, this candidate offers the first real hope of prevention.\n\n*(Word count: 88)*